LifeMD to Report Second Quarter 2025 Financial Results on August 5
LifeMD (Nasdaq: LFMD), a leading virtual primary care provider, has scheduled its second quarter 2025 financial results announcement for August 5, 2025, after market close. The company will host a conference call at 4:30 p.m. Eastern time.
LifeMD operates through a vertically integrated platform featuring a 50-state affiliated medical group, a 22,500-square-foot pharmacy, and a U.S.-based patient care center. The company provides telemedicine services, laboratory and pharmacy access, and specialized treatment for over 200 medical conditions, including primary care, men's and women's health, weight management, and hormone therapy.
LifeMD (Nasdaq: LFMD), un importante fornitore di assistenza primaria virtuale, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 5 agosto 2025, dopo la chiusura del mercato. L'azienda terrà una conference call alle 16:30 ora della costa orientale.
LifeMD opera attraverso una piattaforma integrata verticalmente che comprende un gruppo medico affiliato in tutti i 50 stati, una farmacia di 2.090 metri quadrati e un centro di assistenza pazienti negli Stati Uniti. L'azienda offre servizi di telemedicina, accesso a laboratori e farmacie, e trattamenti specializzati per oltre 200 condizioni mediche, inclusi assistenza primaria, salute maschile e femminile, gestione del peso e terapia ormonale.
LifeMD (Nasdaq: LFMD), un proveedor líder de atención primaria virtual, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 5 de agosto de 2025, después del cierre del mercado. La empresa realizará una conferencia telefónica a las 4:30 p.m., hora del este.
LifeMD opera a través de una plataforma integrada verticalmente que cuenta con un grupo médico afiliado en los 50 estados, una farmacia de 2,090 metros cuadrados y un centro de atención al paciente en EE.UU. La empresa ofrece servicios de telemedicina, acceso a laboratorio y farmacia, y tratamientos especializados para más de 200 condiciones médicas, incluyendo atención primaria, salud masculina y femenina, manejo de peso y terapia hormonal.
LifeMD (나스닥: LFMD)는 선도적인 가상 1차 진료 제공업체로서 2025년 2분기 재무 실적 발표를 2025년 8월 5일 시장 마감 후에 예정하고 있습니다. 회사는 동부 표준시 오후 4시 30분에 컨퍼런스 콜을 진행할 예정입니다.
LifeMD는 미국 50개 주 전역에 제휴된 의료 그룹, 2,090평방피트 규모의 약국, 그리고 미국 내 환자 진료 센터를 포함하는 수직 통합 플랫폼을 운영합니다. 회사는 원격의료 서비스, 검사실 및 약국 접근, 그리고 200개 이상의 의료 질환에 대한 전문 치료를 제공하며, 1차 진료, 남성 및 여성 건강, 체중 관리, 호르몬 치료 등을 포함합니다.
LifeMD (Nasdaq : LFMD), un fournisseur majeur de soins primaires virtuels, a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le 5 août 2025, après la clôture du marché. L'entreprise tiendra une conférence téléphonique à 16h30 heure de l'Est.
LifeMD fonctionne via une plateforme intégrée verticalement comprenant un groupe médical affilié dans les 50 États, une pharmacie de 2 090 mètres carrés et un centre de soins aux patients basé aux États-Unis. La société propose des services de télémédecine, un accès aux laboratoires et aux pharmacies, ainsi que des traitements spécialisés pour plus de 200 affections médicales, incluant les soins primaires, la santé masculine et féminine, la gestion du poids et la thérapie hormonale.
LifeMD (Nasdaq: LFMD), ein führender Anbieter virtueller Primärversorgung, hat die Bekanntgabe seiner Finanzergebnisse für das zweite Quartal 2025 für den 5. August 2025, nach Börsenschluss, geplant. Das Unternehmen wird eine Telefonkonferenz um 16:30 Uhr Eastern Time abhalten.
LifeMD betreibt eine vertikal integrierte Plattform mit einer medizinischen Gruppe, die in allen 50 Bundesstaaten vertreten ist, einer 2.090 Quadratmeter großen Apotheke und einem patientenorientierten Versorgungszentrum in den USA. Das Unternehmen bietet Telemedizin-Dienste, Labor- und Apothekenzugang sowie spezialisierte Behandlungen für über 200 medizinische Erkrankungen, darunter Primärversorgung, Männer- und Frauengesundheit, Gewichtsmanagement und Hormontherapie.
- None.
- None.
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on August 5, 2025, and will host a conference call beginning at 4:30 p.m. Eastern time.
Conference Call & Webcast Details
| Date: | Tuesday, August 5th |
| Time: | 4:30 p.m. Eastern time |
| Toll-Free Dial-In: | 800-445-7795 |
| International Dial-In: | 785-424-1699 |
| Conference ID: | LIFEMD |
| Live & Archived Webcast: | Link |
About LifeMD, Inc.
LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a 22,500-square-foot affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.
Investor Contact
Marc Benathen, Chief Financial Officer
marc@lifemd.com
Media Contact
Jessica Friedeman, Chief Marketing Officer
press@lifemd.com
FAQ
When will LifeMD (LFMD) report Q2 2025 earnings?
How can I join LifeMD's Q2 2025 earnings call?
What services does LifeMD offer?
What is LifeMD's healthcare infrastructure?
